John Divine

John Divine

John Divine is currently an investing reporter at U.S. News & World Report, and was previously an assistant editor at InvestorPlace.com. He has worked variously in the fields of commercial real estate, money management and digital media, working as a financial journalist for most of his professional career.

John has also been a regular contributor to The Motley Fool, and his work also has appeared on AOL DailyFinance.

In 2013, he shortened his bucket list when he saw Warren Buffett live and in the flesh while covering the Berkshire Hathaway Annual Shareholders’ Meeting.

A proud North Carolinian and graduate of Appalachian State University, John majored in Finance & Banking. He enjoys basketball, reading, writing and food. He does not care for the Oxford comma, and he does not require the food he enjoys to be nutritious.

Recent Articles

Orexigen (OREX) Stock Shoots Higher as Contrave Goes on Sale

Orexigen's Contrave joined a couple other FDA-approved weight-loss treatments on the market ... and the OREX product is a serious player.

AAL, DAL and LUV: Airline Stocks Soar on Rate Hike

The nature of oligopolies, the decline of Ebola, and the fall of oil are the three major factors sending airline stocks skyward today.

AMZN: Can Amazon Earnings Whip the Stock Back Into Shape?

Amazon (AMZN) reports third-quarter 2014 earnings on Thursday, and Wall Street again will be focused on razor-thin margins.

Why International Business Machines Corporation, Cisco Systems, Inc., and CSX Corp. Are Today’s 3 Worst Stocks

From a shifting tech landscape to weak forecasts to failed mergers, these three stocks shed major ground on Monday.

Ibio Stock Cratering as Ebola Speculative Bubble Bursts

Ibio (IBIO) and Lakeland Industries (LAKE) both soared as the Ebola panic took hold. Good luck holding on to those short-term gains.